A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
Clinical trial NCT05714072 · RECRUITING
Trial details
- NCT number
- NCT05714072
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-25
- Primary completion
- 2027-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.